跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 108 条关于
“i900”
全部
108
临床试验
59
药物
34
机构
0
资讯
15
去年
Medit and Graphy Form Strategic Alliance to Transform Digital Orthodontics with 3D-Printed Clear Aligners
去年
Nanobiotix's Radioenhancer JNJ-1900 Enters Phase 2 Trial for Unresectable NSCLC
去年
JNJ-1900 Shows Promise in Phase 1 Trial for Advanced Pancreatic Cancer
去年
Nanobiotix's JNJ-1900 Shows Promising Results in Anti-PD-1 Resistant Melanoma Patients
去年
Nanobiotix Secures EU Regulatory Harmonization and New Patent for Cancer Radioenhancer JNJ-1900
9个月前
Tonix Pharmaceuticals Licenses TNX-4900, Novel Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain
5个月前
Tonix Pharmaceuticals Initiates Phase 1 Study of TNX-1900 Intranasal Oxytocin for Migraine Treatment
5个月前
Nanobiotix Reports Promising Early Data from Phase 2 Lung Cancer Trial of JNJ-1900 Radioenhancer
去年
Amgen Announces $900 Million Manufacturing Expansion in Ohio, Creating 350 New Jobs
11个月前
Tonix Pharmaceuticals Advances TNX-2900 to Phase 2 Trial for Prader-Willi Syndrome Following FDA Clearance
第 1 页,共 2 页
上一页
下一页